1. Curaleaf Reports Fourth Quarter and Full Year 2018 Financial and Operational Results
  2. Biome Grow Welcomes Former Ontario Minister of Health, George Smitherman as Senior Vice President of Corporate Affairs
  3. Planet 13 Teams-up with Boxing Legend Mike Tyson
  4. Supreme Cannabis Signs LOI with Malta Enterprises for Cannabis License
  5. Sunniva Launches First Three Cannabis Brands in California
  6. Aurora Cannabis Provides Update on its Strategic Investment in Choom
  7. Emblem Corp. Shareholders Approve Proposed Arrangement with Aleafia Health
  8. Namaste Technologies Announces Auditor Resignation and Provides Corporate Update
  9. SUNNIVA ANNOUNCES CLOSING OF SECOND TRANCHE OF CONVERTIBLE DEBT FINANCING
  10. Aurora Completes Whistler Medical Acquisition
  11. MedMen Reports Second Quarter Fiscal Year 2019 Financial Results
  12. 48 North Releases Second Quarter Financials
  13. Delta 9 Announces Future Expansion Plans
  14. Beverage Trade Network Launches the First-ever Cannabis Drinks Expo
  15. Tilray® to Acquire Manitoba Harvest, the World’s Largest Hemp Food Company
  16. Origin House Acquires Online and Retail Canadian Vape Operator, 180 Smoke
  17. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  18. Treating Yourself Relaunches Medical Cannabis Website
  19. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  20. Supreme Cannabis Announces Q2 2019 Financial Results
  21. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  22. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  23. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  24. Aurora Releases Q2 Financial Results
  25. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  26. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  27. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  28. 48North Closes its $10 million Private Placement
  29. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  30. Planet 13 Announces Customer Traffic for January 2019
  31. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  32. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  33. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  34. What Drove Altria’s Revenue in the Fourth Quarter?
  35. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  36. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  37. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  38. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  39. Origin House Signs Exclusive Agreement with Viola Brands for California
  40. TGOD Completes Knud Jepsen Agreement
  41. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  42. MPX Receives Final Court Approval for Arrangement with iAnthus
  43. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  44. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  45. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  46. MPX Securityholders Approve Business Combination with iAnthus
  47. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  48. Biome Opens the Door to U.S. Investors
  49. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  50. Aurora to Acquire Whistler
  51. Aphria Releases Q2 Results as Founders Step Down
  52. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  53. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  54. Emerald Health Closes Emerald Health Naturals Joint Venture
  55. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  56. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  57. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  58. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  59. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  60. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  61. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  62. The Fastest-Growing Marijuana Stocks in 2019
  63. Biome Announces OTCQB Listing
  64. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  65. Cannabis Stocks Mixed on Monday
  66. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  67. Northland Capital Initiates Coverage on Planet 13 Holdings
  68. Details on Ontario’s New Private Cannabis Retail Lottery
  69. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  70. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  71. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  72. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  73. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  74. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  75. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  76. U.S. House of Representatives Passes the Farm Bill
  77. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  78. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  79. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  80. Altria Moves into the Herd
  81. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  82. Canopy Acquires Storz & Bickel
  83. CANNABIS MEETS HEALTHCARE
  84. Aphria Shares Down this Morning
  85. 48North Has Two Major Announcements
  86. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  87. Cannabis Daily’s Top 35 Stocks Now Updated
  88. iAnthus Announces Third Quarter 2018 Financial Results
  89. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  90. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  91. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  92. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  93. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  94. Cannabis 3.0?
  95. Cannabis firms spent millions marketing their pot last quarter – did it work?
  96. Biome Grow, Now Publicly Traded but Falling Under the Radar
  97. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  98. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  99. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  100. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  101. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  102. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  103. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  104. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  105. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  106. Trump ousts Jeff Sessions as attorney general
  107. Marijuana Stocks Moved Higher On Election Results
  108. Is the cannabis industry armed against privacy breaches?
  109. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  110. Midterm elections and marijuana: Part III, recreational use initiatives
  111. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  112. Cannabis Stocks Reversed Some Losses Last Week
  113. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  114. Forget October: Here’s the Right Marijuana Move for Investors Now
  115. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  116. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  117. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  118. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  119. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  120. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  121. Cannabis Sector Didn’t Fare So Well Last Week
  122. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  123. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  124. Kushco Holdings Joins Sustainable Packaging Coalition
  125. Sales of Marijuana in Colorado Continue to Climb
  126. Monday Morning Coming Down
  127. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  128. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  129. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  130. Home-Use THC and CBD Test Kits Now Available in Canada
  131. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  132. Canada becomes first industrialised nation to legalise cannabis
  133. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  134. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  135. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  136. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  137. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  138. Flower One Commences Trading on the CSE
  139. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  140. Aurora Cannabis Announces Application to List on the NYSE
  141. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  142. Remember When?
  143. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  144. Biome Grow Closes Fundamental Change Transaction
  145. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  146. Cannabis Sector Down After Pepsi’s Statement
  147. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  148. Dixie Brands, Inc. Going Public, Expanding Operations
  149. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  150. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  151. Aphria unveils comprehensive portfolio of adult-use brands
  152. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  153. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  154. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  155. Our first exposure to The Cannabis Society both eye-opening and insightful
  156. Cannabis Sector Stayed in the Green Last Week
  157. Aurora Cannabis releases earnings, confirms U.S. listing plans
  158. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  159. Keep your arms and legs in the car at all times…
  160. Aphria Signs Supply Agreements with all Provinces and Yukon
  161. The Stock That Can’t Stay Out of the News
  162. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  163. Tilray Drops Namaste Contract
  164. Coca-Cola and Aurora. Is it the Real Thing?
  165. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  166. Global Cannabis Partnership Welcomes New Members
  167. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  168. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  169. Aphria Announces Director Resignation and Appointment
  170. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  171. Organigram invests in Hyasynth Biologicals Inc.
  172. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  173. Insights on the Cannabis Industry
  174. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  175. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  176. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  177. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  178. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  179. Cannabis Daily and Puffin Style Media Sponsorships
  180. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  181. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  182. Vertical Integration
  183. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  184. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  185. iAnthus Announces Second Quarter 2018 Financial Results
  186. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  187. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  188. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  189. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  190. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  191. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  192. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  193. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  194. Biome Grow – Investor Awareness Event
  195. Pot stocks rampage amid expectations of more big deals with traditional companies
  196. Cannabis Daily Launches Cannabis Lifestyle Website
  197. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  198. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  199. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  200. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  201. Aphria Signs Agreement with OCS
  202. The OCS Announces its Suppliers
  203. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  204. Weed’s Big Day
  205. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  206. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  207. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  208. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  209. Canopy Growth secures over 100 product listings in Ontario
  210. The Google of Cannabis? Hmm…
  211. Dry Counties
  212. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  213. Kush Bottles Launches Their Canadian Division
  214. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  215. Aurora Cannabis and McGill University Partner in International Research Project
  216. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  217. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  218. THC BioMed Develops Cannabis Beverage
  219. What’s the Analyst Consensus on Aphria?
  220. Canopy Growth Completes Canopy Health Innovations Acquisition
  221. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  222. How Trump’s trade battles are affecting the marijuana industry
  223. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  224. 48North Invites Women To Speak-Up About Their Cannabis Use
  225. ABcann to Acquire Leading B.C. Producer Canna Farms
  226. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  227. The Greenfield 4:20 Fire and its Implications
  228. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  229. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  230. Marijuana operator Acreage Holdings announces landmark $119 million funding
  231. Cannabis Sector Continued to Slide Last Week
  232. Aphria provides update on investments
  233. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  234. Step into the first virtual reality cannabis dispensary
  235. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  236. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  237. Selling Cannabis in Jamaica – Wait…What?
  238. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  239. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  240. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  241. Canopy Growth Moves to Acquire Hiku Brands Company
  242. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  243. Alberta Announces the ‘Lucky 13’
  244. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  245. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  246. Analyst Recommendations for Two Leading Cannabis Stocks
  247. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  248. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  249. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  250. CEO Hotline: The Cannabis Executive Search Agency
  251. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  252. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  253. Why Canopy Growth Corp’s Shares Plunged 12% Today
  254. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  255. Cann Group secures Australia’s largest medicinal cannabis operation
  256. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  257. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  258. Cannabis Drinks Gaining Visibility
  259. B.C. Announces Central Cannabis Warehouse and Online Platform
  260. Six Key Differentiation Points for the Cannabis Market in Canada
  261. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  262. Cultivator Catalyst Corp to go public with tech firm Orca
  263. Move Over Tech: Marijuana Stocks Are the New Star
  264. The Post-Prohibition Era in Canada Begins
  265. Canadian Senate Approves Bill C-45
  266. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  267. Weed VR – Future Tech Today
  268. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  269. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  270. Biome Grow announces agreement to acquire Weed Virtual Retail
  271. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  272. CannabisMD and CBD’s Medicinal Application
  273. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  274. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  275. Welcome to Cannada -Part 3. The New Cannabis Economy
  276. Cannabis Delivery Services: Curation and Connection
  277. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  278. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  279. Trump Signals Support for Legislation Easing US Ban on Pot
  280. Large Indoor Hydroponic Facility – New On the CSE
  281. A Hitchhiker’s Guide to Recreational Cannabis
  282. CEO of Lift & Co’s Consumer-Centric Vision
  283. On the Morning of Canadian Senate Vote, Weed Stocks Down
  284. 2nd Annual O’Cannabiz Conference Toronto
  285. Now Growing More Than Tomatoes & Cucumbers
  286. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  287. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  288. Welcome to Cannada. Part I – The Canadian Cannabis Future
  289. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  290. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  291. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  292. On the Verge of Becoming Canada’s Largest Cannabis Producer
  293. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  294. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  295. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  296. Canopy Growth Announces Five Retail Locations in Saskatchewan
  297. MedMen CEO Sees Untapped Potential in Marijuana Market
  298. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  299. Meet Nova Scotia’s 3 legal cannabis growers
  300. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  301. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  302. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  303. Cannabis Sector Back in the Red for Week Ended May 25
  304. What Investors Are Paying for Cannabis Sector’s Forward Sales
  305. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  306. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  307. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  308. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  309. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  310. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  311. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  312. Diagnostics, Testing and Support – The Coming Wave
  313. From the Big Smoke to the Big Board
  314. Biome Grow expects completion of first province-based cannabis production facility this year
  315. Oils – Are They Secret Sauce to Profitability?
  316. Organigram Receives Permit to Export Medical Cannabis to Australia
  317. Morning Briefing -Top 9 Stocks To Follow
  318. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  319. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  320. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  321. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  322. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  323. Aurora Cannabis to Acquire MedReleaf
  324. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  325. New on the TSX: InMed Pharmaceuticals
  326. Canadian Cannabis Stocks Continue to Dominate the Market
  327. Organigram Announces First International Expansion Investment
  328. Moody’s Expects Marijuana to See Limited Revenue
  329. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  330. How to Invest in Cannabis – In Its Many Forms
  331. Should You Invest In Cannabis Stocks?
  332. Top 4 Marijuana Stocks to Watch
  333. CEO Hotline Puts You In The Know
  334. 10 Canadian Marijuana Stocks for Your Portfolio
  335. Pot Stocks To Buy Now
  336. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  337. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  338. American Cannabis Stocks
  339. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  340. Saw that it was covered
  341. Chooses to enjoy a pleasure
  342. These matters to this principle
  343. Heaven and earth seem
  344. Had grass morning
  345. Where they abused her
  346. Replenish itself
  347. I neglect my talents
  348. Grammar resulting language
  349. Where it came from it
Banner Top
  1. Curaleaf Reports Fourth Quarter and Full Year 2018 Financial and Operational Results
  2. Biome Grow Welcomes Former Ontario Minister of Health, George Smitherman as Senior Vice President of Corporate Affairs
  3. Planet 13 Teams-up with Boxing Legend Mike Tyson
  4. Supreme Cannabis Signs LOI with Malta Enterprises for Cannabis License
  5. Sunniva Launches First Three Cannabis Brands in California
  6. Aurora Cannabis Provides Update on its Strategic Investment in Choom
  7. Emblem Corp. Shareholders Approve Proposed Arrangement with Aleafia Health
  8. Namaste Technologies Announces Auditor Resignation and Provides Corporate Update
  9. SUNNIVA ANNOUNCES CLOSING OF SECOND TRANCHE OF CONVERTIBLE DEBT FINANCING
  10. Aurora Completes Whistler Medical Acquisition
  11. MedMen Reports Second Quarter Fiscal Year 2019 Financial Results
  12. 48 North Releases Second Quarter Financials
  13. Delta 9 Announces Future Expansion Plans
  14. Beverage Trade Network Launches the First-ever Cannabis Drinks Expo
  15. Tilray® to Acquire Manitoba Harvest, the World’s Largest Hemp Food Company
  16. Origin House Acquires Online and Retail Canadian Vape Operator, 180 Smoke
  17. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  18. Treating Yourself Relaunches Medical Cannabis Website
  19. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  20. Supreme Cannabis Announces Q2 2019 Financial Results
  21. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  22. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  23. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  24. Aurora Releases Q2 Financial Results
  25. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  26. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  27. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  28. 48North Closes its $10 million Private Placement
  29. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  30. Planet 13 Announces Customer Traffic for January 2019
  31. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  32. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  33. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  34. What Drove Altria’s Revenue in the Fourth Quarter?
  35. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  36. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  37. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  38. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  39. Origin House Signs Exclusive Agreement with Viola Brands for California
  40. TGOD Completes Knud Jepsen Agreement
  41. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  42. MPX Receives Final Court Approval for Arrangement with iAnthus
  43. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  44. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  45. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  46. MPX Securityholders Approve Business Combination with iAnthus
  47. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  48. Biome Opens the Door to U.S. Investors
  49. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  50. Aurora to Acquire Whistler
  51. Aphria Releases Q2 Results as Founders Step Down
  52. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  53. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  54. Emerald Health Closes Emerald Health Naturals Joint Venture
  55. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  56. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  57. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  58. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  59. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  60. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  61. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  62. The Fastest-Growing Marijuana Stocks in 2019
  63. Biome Announces OTCQB Listing
  64. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  65. Cannabis Stocks Mixed on Monday
  66. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  67. Northland Capital Initiates Coverage on Planet 13 Holdings
  68. Details on Ontario’s New Private Cannabis Retail Lottery
  69. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  70. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  71. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  72. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  73. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  74. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  75. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  76. U.S. House of Representatives Passes the Farm Bill
  77. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  78. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  79. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  80. Altria Moves into the Herd
  81. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  82. Canopy Acquires Storz & Bickel
  83. CANNABIS MEETS HEALTHCARE
  84. Aphria Shares Down this Morning
  85. 48North Has Two Major Announcements
  86. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  87. Cannabis Daily’s Top 35 Stocks Now Updated
  88. iAnthus Announces Third Quarter 2018 Financial Results
  89. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  90. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  91. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  92. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  93. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  94. Cannabis 3.0?
  95. Cannabis firms spent millions marketing their pot last quarter – did it work?
  96. Biome Grow, Now Publicly Traded but Falling Under the Radar
  97. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  98. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  99. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  100. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  101. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  102. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  103. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  104. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  105. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  106. Trump ousts Jeff Sessions as attorney general
  107. Marijuana Stocks Moved Higher On Election Results
  108. Is the cannabis industry armed against privacy breaches?
  109. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  110. Midterm elections and marijuana: Part III, recreational use initiatives
  111. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  112. Cannabis Stocks Reversed Some Losses Last Week
  113. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  114. Forget October: Here’s the Right Marijuana Move for Investors Now
  115. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  116. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  117. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  118. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  119. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  120. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  121. Cannabis Sector Didn’t Fare So Well Last Week
  122. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  123. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  124. Kushco Holdings Joins Sustainable Packaging Coalition
  125. Sales of Marijuana in Colorado Continue to Climb
  126. Monday Morning Coming Down
  127. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  128. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  129. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  130. Home-Use THC and CBD Test Kits Now Available in Canada
  131. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  132. Canada becomes first industrialised nation to legalise cannabis
  133. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  134. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  135. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  136. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  137. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  138. Flower One Commences Trading on the CSE
  139. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  140. Aurora Cannabis Announces Application to List on the NYSE
  141. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  142. Remember When?
  143. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  144. Biome Grow Closes Fundamental Change Transaction
  145. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  146. Cannabis Sector Down After Pepsi’s Statement
  147. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  148. Dixie Brands, Inc. Going Public, Expanding Operations
  149. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  150. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  151. Aphria unveils comprehensive portfolio of adult-use brands
  152. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  153. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  154. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  155. Our first exposure to The Cannabis Society both eye-opening and insightful
  156. Cannabis Sector Stayed in the Green Last Week
  157. Aurora Cannabis releases earnings, confirms U.S. listing plans
  158. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  159. Keep your arms and legs in the car at all times…
  160. Aphria Signs Supply Agreements with all Provinces and Yukon
  161. The Stock That Can’t Stay Out of the News
  162. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  163. Tilray Drops Namaste Contract
  164. Coca-Cola and Aurora. Is it the Real Thing?
  165. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  166. Global Cannabis Partnership Welcomes New Members
  167. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  168. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  169. Aphria Announces Director Resignation and Appointment
  170. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  171. Organigram invests in Hyasynth Biologicals Inc.
  172. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  173. Insights on the Cannabis Industry
  174. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  175. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  176. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  177. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  178. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  179. Cannabis Daily and Puffin Style Media Sponsorships
  180. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  181. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  182. Vertical Integration
  183. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  184. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  185. iAnthus Announces Second Quarter 2018 Financial Results
  186. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  187. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  188. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  189. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  190. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  191. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  192. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  193. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  194. Biome Grow – Investor Awareness Event
  195. Pot stocks rampage amid expectations of more big deals with traditional companies
  196. Cannabis Daily Launches Cannabis Lifestyle Website
  197. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  198. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  199. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  200. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  201. Aphria Signs Agreement with OCS
  202. The OCS Announces its Suppliers
  203. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  204. Weed’s Big Day
  205. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  206. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  207. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  208. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  209. Canopy Growth secures over 100 product listings in Ontario
  210. The Google of Cannabis? Hmm…
  211. Dry Counties
  212. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  213. Kush Bottles Launches Their Canadian Division
  214. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  215. Aurora Cannabis and McGill University Partner in International Research Project
  216. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  217. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  218. THC BioMed Develops Cannabis Beverage
  219. What’s the Analyst Consensus on Aphria?
  220. Canopy Growth Completes Canopy Health Innovations Acquisition
  221. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  222. How Trump’s trade battles are affecting the marijuana industry
  223. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  224. 48North Invites Women To Speak-Up About Their Cannabis Use
  225. ABcann to Acquire Leading B.C. Producer Canna Farms
  226. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  227. The Greenfield 4:20 Fire and its Implications
  228. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  229. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  230. Marijuana operator Acreage Holdings announces landmark $119 million funding
  231. Cannabis Sector Continued to Slide Last Week
  232. Aphria provides update on investments
  233. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  234. Step into the first virtual reality cannabis dispensary
  235. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  236. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  237. Selling Cannabis in Jamaica – Wait…What?
  238. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  239. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  240. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  241. Canopy Growth Moves to Acquire Hiku Brands Company
  242. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  243. Alberta Announces the ‘Lucky 13’
  244. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  245. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  246. Analyst Recommendations for Two Leading Cannabis Stocks
  247. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  248. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  249. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  250. CEO Hotline: The Cannabis Executive Search Agency
  251. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  252. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  253. Why Canopy Growth Corp’s Shares Plunged 12% Today
  254. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  255. Cann Group secures Australia’s largest medicinal cannabis operation
  256. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  257. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  258. Cannabis Drinks Gaining Visibility
  259. B.C. Announces Central Cannabis Warehouse and Online Platform
  260. Six Key Differentiation Points for the Cannabis Market in Canada
  261. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  262. Cultivator Catalyst Corp to go public with tech firm Orca
  263. Move Over Tech: Marijuana Stocks Are the New Star
  264. The Post-Prohibition Era in Canada Begins
  265. Canadian Senate Approves Bill C-45
  266. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  267. Weed VR – Future Tech Today
  268. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  269. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  270. Biome Grow announces agreement to acquire Weed Virtual Retail
  271. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  272. CannabisMD and CBD’s Medicinal Application
  273. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  274. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  275. Welcome to Cannada -Part 3. The New Cannabis Economy
  276. Cannabis Delivery Services: Curation and Connection
  277. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  278. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  279. Trump Signals Support for Legislation Easing US Ban on Pot
  280. Large Indoor Hydroponic Facility – New On the CSE
  281. A Hitchhiker’s Guide to Recreational Cannabis
  282. CEO of Lift & Co’s Consumer-Centric Vision
  283. On the Morning of Canadian Senate Vote, Weed Stocks Down
  284. 2nd Annual O’Cannabiz Conference Toronto
  285. Now Growing More Than Tomatoes & Cucumbers
  286. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  287. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  288. Welcome to Cannada. Part I – The Canadian Cannabis Future
  289. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  290. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  291. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  292. On the Verge of Becoming Canada’s Largest Cannabis Producer
  293. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  294. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  295. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  296. Canopy Growth Announces Five Retail Locations in Saskatchewan
  297. MedMen CEO Sees Untapped Potential in Marijuana Market
  298. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  299. Meet Nova Scotia’s 3 legal cannabis growers
  300. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  301. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  302. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  303. Cannabis Sector Back in the Red for Week Ended May 25
  304. What Investors Are Paying for Cannabis Sector’s Forward Sales
  305. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  306. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  307. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  308. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  309. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  310. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  311. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  312. Diagnostics, Testing and Support – The Coming Wave
  313. From the Big Smoke to the Big Board
  314. Biome Grow expects completion of first province-based cannabis production facility this year
  315. Oils – Are They Secret Sauce to Profitability?
  316. Organigram Receives Permit to Export Medical Cannabis to Australia
  317. Morning Briefing -Top 9 Stocks To Follow
  318. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  319. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  320. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  321. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  322. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  323. Aurora Cannabis to Acquire MedReleaf
  324. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  325. New on the TSX: InMed Pharmaceuticals
  326. Canadian Cannabis Stocks Continue to Dominate the Market
  327. Organigram Announces First International Expansion Investment
  328. Moody’s Expects Marijuana to See Limited Revenue
  329. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  330. How to Invest in Cannabis – In Its Many Forms
  331. Should You Invest In Cannabis Stocks?
  332. Top 4 Marijuana Stocks to Watch
  333. CEO Hotline Puts You In The Know
  334. 10 Canadian Marijuana Stocks for Your Portfolio
  335. Pot Stocks To Buy Now
  336. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  337. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  338. American Cannabis Stocks
  339. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  340. Saw that it was covered
  341. Chooses to enjoy a pleasure
  342. These matters to this principle
  343. Heaven and earth seem
  344. Had grass morning
  345. Where they abused her
  346. Replenish itself
  347. I neglect my talents
  348. Grammar resulting language
  349. Where it came from it
  • Increased revenue sequentially by 39% to $29.9 million.
  • Continued to perform favorably in California with eight retail locations reporting a combined $23.7 million in revenue, representing a 28% quarter-over-quarter increase.
  • Increased overall gross profit margin to 53%, compared to 45% in the previous quarter.
  • Appointed key personnel to the management team, including Michael Kramer as CFO.
  • During the quarter, closed on acquisition of vertically-integrated license in Scottsdale, Arizona and dispensary license in Emeryville, California.

LOS ANGELES — MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) today released its consolidated financial results for the second quarter of fiscal 2019. All financial information for the 13-week period ended December 29, 2018 is reported in U.S. dollars, unless otherwise indicated.

Management Commentary

“Our strong second quarter results support MedMen’s commitment to drive strong retail and sales performance, while efficiently scaling the Company and executing on our growth strategy,” said Adam Bierman, MedMen chief executive officer and co-founder. “As we emphasized last quarter, we are in a new phase of growth, one focused on continuing to operationalize our industry-leading retail footprint and increasing our profitability. We are confident in the team we’ve built to drive our success.”

After going public almost one year ago, MedMen has established a track record of growth and success. With approximately 7% market share in California, the largest cannabis market in the U.S., the Company is planning to open 16 new locations across the U.S. in calendar 2019. Of the 16 new locations, 12 will be based in Florida, where MedMen is licensed for up to 30 locations. Additionally, four retail sites in Florida are expected to open in the next 90 days in the following locations: Key West, Orlando, West Palm Beach, and St. Petersburg.

Second Quarter 2019 Overview

Financial Results:

  • Systemwide sales revenue of $29.9 million, which represents at 39.1% quarter-over-quarter increase over fiscal 2019 first quarter ended September 30, 2018.
  • Gross profit margin improved to 53% from 45% in the prior quarter due to unrealized gain on changes in fair value of biological assets.
  • Company’s eight retail locations in California reported a combined $23.7 million in revenue, a 28% quarter-over-quarter increase.

Corporate Developments:

  • Signed definitive agreement in December to acquire PharmaCann in an all-stock transaction. The transaction will double MedMen’s geographic footprint to 12 states, which account for over 50% of the U.S. population.
  • Expanded California footprint into Northern California through the signing of definitive agreements for the acquisitions of a retail license in Emeryville and a microbusiness license for retail, distribution, cultivation and manufacturing cannabis onsite in San Jose. The first transaction closed in Q2 2019 and the second transaction closed in Q3 2019.
  • Signed definitive agreement to acquire the retail operations and license for a store in Santa Ana, California, through an all-stock transaction with Captor Capital Corp. This location was already operating under the MedMen brand through a management contract. Transaction closed in Q3 2019.
  • Closed on acquisition of Omaha Management Services, LLC, which owns Monarch, a Arizona-based vertically-integrated medical license holder with a flagship retail location in Scottsdale, plus cultivation and processing operations.

Brand Strategy:

  • Launched a comprehensive suite of new cannabis products under the brand [statemade], which are currently being sold in MedMen’s Nevada stores.
  • Announced the completion of investment in California-based flower brand Old Pal, which provides every day, high-quality cannabis flower for customers.

People:

  • Appointed Michael Kramer as chief financial officer. Mr. Kramer offers three decades of retail experience and has excelled in both operational and financial roles, including as CFO of high-profile retailers such as Apple Retail Inc., Forever 21, and Abercrombie & Fitch.
  • Appointed Ben Cook as chief operating officer. Mr. Cook has extensive experience leading omnichannel distribution, global market expansion and supply chain optimization. His experience executing complex strategies for global, high-growth companies, including Apple, Sam’s Club, and Target is invaluable to MedMen’s growing multi-state operations and expansion plans.

Capital Markets and Financing Activities:

  • Announced relationship with newly formed Treehouse Real Estate Investment Trust (“Treehouse”), a cannabis-focused REIT that has now raised $133 million to acquire properties from MedMen and other cannabis real estate.
  • Closed a $77 million senior secured term loan with funds managed by Hankey Capital and with an affiliate of Stable Road Capital.
  • Closed, on December 5, a $56 million bought deal equity financing, issuing 13,640,000 units at a price per unit of $4.11, with each unit being comprised of one Class B subordinate voting share and one Class B subordinate voting share purchase warrant. The exercise price of such warrants is US$5.16 per share and they are exercisable for a term expiring on September 27, 2021.
  • Uplisted to the OTCQX® Best Market by OTC Markets Group under the ticker symbol “MMNFF” on October 24.

Subsequent Events

Corporate Developments:

  • Closed acquisition of Seven Point, a licensed medical cannabis dispensary located in Oak Park, Illinois.
  • Closed acquisition of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as “Level Up,” in a cash and stock transaction valued at $33 million on February 12, 2019. Level Up holds licenses for two vertically-integrated operations in Arizona, including retail locations in Scottsdale and Tempe and 25,000 square feet of cultivation and production capacity in Tempe and Phoenix. The Company also received a 40% stake in top-selling brand K.I.N.D. Concentrates, which is currently distributed in over 90% of the dispensaries in Arizona.

Capital Markets and Financing Activities:

  • Completed the sale of three properties to Treehouse for net proceeds of approximately $18.4 million, after repayment of debt.

Second Quarter Fiscal Year 2019 Review

In an effort to increase transparency, provide a better understanding of MedMen’s business, and ensure sales comparability between years, the Company is basing accounting on the 4-5-4 calendar structure. Additionally, the Company is now breaking out performance in the MD&A by retail, cultivation and manufacturing, corporate SG&A and pre-opening expenses.

For the second quarter of fiscal 2019, systemwide revenue was $29.9 million. This represents a 39.1% quarter-over-quarter increase over the first quarter of fiscal 2019 ended September 30, 2018. Systemwide revenue, pro forma to include pending acquisitions that have not yet closed, would have been $49.5 million for the quarter.

Retail: Systemwide retail revenue for the quarter is based on 16 retail stores that were operational at the end of the quarter. This includes the MedMen Paradise location near McCarran International Airport in Las Vegas, which opened in October, and the MedMen Scottsdale location in Arizona, which began to be included in MedMen’s results in December following the closing of the Monarch acquisition.

Strong systemwide retail revenue for the quarter is primarily attributable to MedMen’s stores in Southern California’s recreational market. In California, the Company’s eight retail locations reported a combined $23.7 million in revenue, which represents a 28% quarter-over-quarter increase.

Cultivation and Manufacturing: For the second quarter of fiscal 2019, the Company reported a $4.9 million EBITDA loss for cultivation and manufacturing, of which approximately $4 million is related to costs associated with the Company’s first full-scale factory, Project Mustang in Nevada, which has already begun producing [statemade] products.

Corporate SG&A: During the second quarter, the Company continued to make significant investments in building the corporate infrastructure and team required to execute its strategy for long-term growth. Corporate SG&A includes corporate infrastructure and growth initiatives such as corporate payroll, sales and marketing, technology, among other things. Of the total $40.9 million corporate SG&A expenses, $14.4 million was corporate payroll, which included the buildout of several teams within the Company including finance and accounting, digital, business intelligence and marketing. SG&A expenses also included $8.6 million in marketing and branding as compared to $4.8 million in the first quarter of 2019.

Pre-Opening Expenses: The Company incurred $3.0 million of pre-opening expenses in the second fiscal quarter of 2019, primarily driven by rent expenses of retail stores, cultivation/manufacturing sites and facilities that are not yet operational.

Gross profit for the second quarter, before biological asset adjustment, was $13.3 million, as compared to $0.5 million in the second fiscal quarter of last year. For the second quarter, gross profit margin after biological asset adjustment was 53%, compared to 45% in the previous quarter.

For the second quarter 2019, the Company reported a total net loss of $64.6 million compared to a net loss of $66.5 million for the first quarter. Net loss per share attributable to the Company in the second quarter was $0.25 versus a net loss of $0.27 for the first quarter.

ADDITIONAL INFORMATION

Additional information relating to the Company’s second quarter 2019 results is available in the Company’s Interim Financial Statements and related Management Discussion & Analysis (“MD&A”) filed on SEDAR at www.sedar.com.

MedMen refers to certain non-IFRS financial measures such as annualized sales per square foot, Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA), Four Wall EBITDA, and adjusted EBITDA (earnings defined as earnings before interest, taxes, depreciation, amortization, less certain non-cash equity compensation expense, including one-time transaction fees and all other non-cash items). These measures do not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other issuers.

Please see the supplemental information (unaudited) regarding non-IFRS financial measures at the end of this press release and the MD&A for more detailed information regarding non-IFRS financial measures.

CONFERENCE CALL AND WEBCAST:

MedMen Enterprises will host a conference call and audio webcast with Chief Executive Officer and Co-Founder Adam Bierman and Chief Financial Officer Michael Kramer today at 5:00 pm Eastern to discuss the financial results in further detail.

Webcast Information:

A live audio webcast of the call will be available on the Events and Presentations section of MedMen’s website at: https://investors.medmen.com/events-and-presentations/default.aspx.

Calling Information:

Toll Free Dial-In Number: (844) 559-7829
International Dial-In Number: (647) 689-5387
Conference ID: 9283806

ABOUT MEDMEN:

MedMen is a cannabis retailer with operations across the U.S. and flagship stores in Los Angeles, Las Vegas and New York. MedMen’s mission is to provide an unparalleled experience that invites the world to discover the remarkable benefits of cannabis because a world where cannabis is legal and regulated is a safer, healthier and happier world.

Learn more at www.medmen.com

California Market Share by Revenue

For the 13 weeks ended December 29, 2018, the State of California collected $50.8 million in excise taxes at a rate of 15%, which equates to approximately $338.7 million in retail sales according to the California Department of Tax and Fee Administration (see http://cdtfa.ca.gov/news/19-02.htm). The Company’s California stores reported $23.7 million in revenue over the same period, which equates to an approximate 7% market share.

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only MedMen’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but are not limited to, information concerning the proposed acquisition of PharmaCann LLC (the “PharmaCann Acquisition”), expectations regarding whether the PharmaCann Acquisition will be consummated, including whether conditions to the consummation of the PharmaCann Acquisition will be satisfied and whether the PharmaCann Acquisition will be completed on the current terms, the timing for completing the PharmaCann Acquisition, expectations for the effects of the PharmaCann Acquisition (including on the Company’s footprint and asset base) on the ability of the Company to successfully achieve business objectives, expectations regarding the number and location of additional stores to be opened by the Company in the next 90 days and during calendar 2019 and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, MedMen is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedMen to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, MedMen has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the inability to consummate the PharmaCann Acquisition; the failure to obtain requisite regulatory approvals and third party consents and the failure to satisfy other conditions to the consummation of the PharmaCann Acquisition, which could impact closing or closing on the proposed terms and schedule; the potential impact of the announcement or consummation of the PharmaCann Acquisition on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the PharmaCann Acquisition. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although MedMen believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and MedMen does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to MedMen or persons acting on its behalf is expressly qualified in its entirety by this notice.

MEDMEN ENTERPRISES INC.
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
AS OF DECEMBER 29, 2018 AND JUNE 30, 2018
(Amounts Expressed in United States Dollars Unless Otherwise Stated)

December 29,
2018

June 30,

2018

ASSETS
Current Assets:
Cash and Cash Equivalents $ 78,219,490 $ 79,159,970
Restricted Cash 3,164,980 6,163,599
Accounts Receivable 534,283 318,159
Current Portion of Prepaid Rent – Related Party 1,922,038 1,898,863
Prepaid Expenses 16,044,104 9,387,047
Biological Assets 2,672,981 1,952,580
Inventory 13,133,638 6,248,754
Other Current Assets 22,357,390 2,790,772
Due from Related Party 5,999,146 3,509,035
Total Current Assets 144,048,050 111,428,779
Prepaid Rent – Related Party, Net of Current Portion 1,681,474 2,652,149
Property and Equipment, Net 131,004,726 88,748,447
Intangible Assets, Net 96,339,102 48,792,757
Goodwill 84,818,127 18,165,161
Other Assets 8,561,933 12,403,049
TOTAL ASSETS $ 466,453,412 $ 282,190,342
LIABILITIES AND SHAREHOLDERS’ EQUITY
LIABILITIES:
Current Liabilities:
Accounts Payable and Accrued Liabilities $ 26,204,120 $ 18,001,505
Other Current Liabilities 14,856,540 1,186,148
Derivative Liabilities 7,089,100
Current Portion of Finance Lease Liability 307,181
Current Portion of Notes Payable 33,487,387 52,353,625
Due to Related Party 5,798,301 9,858,445
Total Current Liabilities 87,742,629 81,399,723
Non-Current Liabilities:
Finance Lease Liability, Net of Current Portion 6,539,888
Other Non-Current Liabilities, Net of Current Portion 17,547,652
Notes Payable, Net of Current Portion 62,920,336 3,593,334
Total Non-Current Liabilities 87,007,876 3,593,334
TOTAL LIABILITIES 174,750,505 84,993,057
SHAREHOLDERS’ EQUITY:
Share Capital 288,042,748 129,145,994
Additional Paid-In Capital 80,071,402 47,091,271
Accumulated Deficit (97,810,015 ) (66,647,221 )
Total Equity Attributable to Shareholders of MedMen 270,304,135 109,590,044
Non-Controlling Interest 21,398,772 87,607,241
TOTAL SHAREHOLDERS’ EQUITY 291,702,907 197,197,285
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 466,453,412 $ 282,190,342
MEDMEN ENTERPRISES INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
13 AND 26 WEEKS ENDED DECEMBER 29, 2018 AND THREE AND SIX MONTHS ENDED DECEMBER 31, 2017
(Amounts Expressed in United States Dollars Unless Otherwise Stated)
13 Weeks Ended Three Months Ended 26 Weeks Ended Six Months Ended
December 29, December 31, December 29, December 31,
2018 2017 2018 2017
Revenue $ 29,930,358 $ 3,075,187 $ 51,390,553 $ 4,881,742
Cost of Goods Sold 16,629,783 2,564,202 26,439,116 3,768,988
Gross Profit Before Fair Value Adjustments 13,300,575 510,985 24,951,437 1,112,754
Changes in Fair Value of Inventory Sold (244,343 ) (2,196,924 )
Unrealized Gain on Changes in Fair Value of

Biological Assets

2,878,271 2,882,915
Gross Profit 15,934,503 510,985 25,637,428 1,112,754
Expenses:
General and Administrative 65,696,688 9,531,722 131,436,138 14,668,415
Sales and Marketing 8,602,293 357,299 13,402,526 528,081
Depreciation and Amortization 3,423,677 708,783 5,873,997 1,387,001
Total Expenses 77,722,658 10,597,804 150,712,661 16,583,497
Loss from Operations (61,788,155 ) (10,086,819 ) (125,075,233 ) (15,470,743 )
Other Expense (Income):
Interest Expense 2,886,674 669,130 5,296,706 1,017,717
Interest Income (284,889 ) (284,889 )
Amortization of Debt Discount 1,384,186 1,442,944
Change in Fair Value of Derivative Liabilities (5,389,178 ) (6,163,107 )
Unrealized Gain on Changes in Fair Value

of Investments

(1,194,000 ) (1,194,000 )
Other Expense 3,152,422 3,258,049
Total Other Expense (Income) 555,215 669,130 2,355,703 1,017,717
Loss Before Provision for Income Taxes (62,343,370 ) (10,755,949 ) (127,430,936 ) (16,488,460 )
Provision for Income Taxes 2,226,849 275,878 3,635,507 275,878
Net Loss and Comprehensive Loss (64,570,219 ) (11,031,827 ) (131,066,443 ) (16,764,338 )
Net Loss and Comprehensive Loss

Attributable to Non-Controlling Interest

45,885,355 99,903,648 423,804
Net Loss and Comprehensive Loss

Attributable to MedMen Enterprises Inc.

$ (18,684,864 ) $ (11,031,827 ) $ (31,162,795 ) $ (16,340,534 )
Loss Per Share – Basic and Diluted
Attributable to MedMen Enterprises

Shareholders

$ (0.25 ) $ (0.57 )
Weighted-Average Shares Outstanding –

Basic and Diluted

74,243,033 54,950,660
MEDMEN ENTERPRISES INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE 26 WEEKS ENDED DECEMBER 29, 2018 AND SIX MONTHS ENDED DECEMBER 31, 2017
(Amounts Expressed in United States Dollars Unless Otherwise Stated)
26 Weeks

Ended

Six Months Ended
December 29, December 31,
2018 2017
CASH FLOW FROM OPERATING ACTIVITIES:
Net Loss $ (131,066,443 ) $ (16,764,338 )
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Unrealized Gain on Changes in Fair Value of Biological Assets (2,882,915 )
Changes in Fair Value of Inventory Sold 2,196,924
Depreciation and Amortization 6,324,661 1,500,431
Amortization of Debt Discount and Loan Origination Fees 2,001,820
Loss on Sale of Property 2,626,216
Accretion of Deferred Gain on Sale of Property (84,995 )
Unrealized Gain on Change in Fair Value of Investments (1,194,000 )
Loss on Extinguishment of Debt 715,979
Share-Based Compensation 22,653,899 539,916
Shares Issued for Acquisition Costs 747,562
Change in Fair Value of Derivative Liabilities (6,163,107 )
Changes in Operating Assets and Liabilities:
Accounts Receivable (183,324 ) (323,290 )
Prepaid Rent – Related Party 947,500 1,100,000
Prepaid Expenses (6,657,057 ) (2,150,754 )
Other Current Assets (7,777,816 )
Biological Assets (34,410 )
Inventory (5,247,388 ) (8,224,108 )
Due from Related Party (2,490,111 ) (5,618,504 )
Other Assets 3,841,116 (455,502 )
Accounts Payable and Accrued Liabilities 6,988,188 15,187,349
Other Current Liabilities (6,204,608 ) (1,464,568 )
Due to Related Party (4,060,144 ) (2,098,270 )
NET CASH USED IN OPERATING ACTIVITIES (125,002,453 ) (18,771,638 )
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of Property and Equipment (55,261,730 ) (13,263,308 )
Investments (8,304,833 )
Proceeds from Sale of Property 24,073,319
Purchase of Intangible Assets (1,260 )
Purchase of Management Agreement (2,000,000 )
Acquisition of Businesses, Net of Cash Acquired (30,686,541 )
Restricted Cash 2,998,619 (472,136 )
NET CASH USED IN INVESTING ACTIVITIES (67,181,166 ) (15,736,704 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of MedMen Corp Redeemable Shares for Cash 115,289,679
Exercise of Warrants for MedMen Corp Redeemable Shares 8,521,268
Contributions from Members 21,904,035
Proceeds from Issuance of Notes Payable 93,943,539
Principal Repayments of Notes Payable (24,739,101 ) (3,959,965 )
Principal Repayments of Capital Lease Liability (42,775 )
Debt Issuance Costs (2,019,472 )
Cash Received from Issuance of Class D Units 9,850,000
Contributions – Non-Controlling Interest 290,000 4,231,214
NET CASH PROVIDED BY FINANCING ACTIVITIES 191,243,139 32,025,284
NET DECREASE IN CASH AND CASH EQUIVALENTS (940,480 ) (2,483,058 )
Cash and Cash Equivalents, Beginning of Period 79,159,970 5,720,026
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 78,219,490 $ 3,236,968
CASH PAID DURING PERIOD FOR:
Interest $ 3,732,632 $ 762,657
OTHER NON-CASH INVESTING AND FINANCING ACTIVITIES:
Net Assets Acquired through Management Agreement $ $ 4,690,505
Derivative Liability Incurred on Issuance of Equity $ 13,252,207 $
Issuance of Subordinate Voting Shares for Other Assets $ 1,946,290 $
Issuance of MedMen Corp Redeemable Shares for Other Assets $ 343,678 $
Redemption of MedMen Corp Redeemable Shares $ 17,994,369 $
Debt Discount Recognized Upon Issuance of Warrants $ 18,694,985 $
Debt Discount Recognized Upon Issuance of Subordinate Voting Shares $ 185,511 $
Conversion of Convertible Notes into Equity $ 3,802,381 $
Issuance of MedMen Corp Redeemable Shares for Repayment of Notes Payable $ 6,759,125 $
Asset Acquired Under Sales-Leaseback (Finance Lease) $ 6,889,844 $
Issuance of Note Payable Related to Purchase of Management Agreement $ $ 2,000,000
Deferred Gain on Sales/Leaseback $ 5,666,274 $
Issuance of Note Payable Related to Purchase of Property and Equipment $ $ 2,025,000
MEDMEN ENTERPRISES INC.
NON-IFRS RECONCILIATION
13 AND 26 WEEKS ENDED DECEMBER 29, 2018 AND THREE AND SIX MONTHS ENDED DECEMBER 31, 2017
(Amounts Expressed in United States Dollars Unless Otherwise Stated)
13 Weeks Ended Three Months Ended 26 Weeks Ended Six Months Ended
December 29, December 31, December 29, December 31,
2018 2017 2018 2017
Net Loss (IFRS) $ (64,570,219 ) $ (11,031,827 ) $ (131,066,443 ) $ (16,764,338 )
Add (Deduct) Impact of:
Transaction Costs 5,381,648 2,211,536 $ 6,804,999 2,144,611
Share-Based Compensation 11,470,363 288,494 22,653,899 539,916
Other Non-Cash Operating Costs (6,064,684 ) (4,785,050 )
Total Adjustments 10,787,327 2,500,030 24,673,848 2,684,527
Adjusted Net Loss (Non-IFRS) $ (53,782,892 ) $ (8,531,797 ) $ (106,392,595 ) $ (14,079,811 )
Net Loss (IFRS) $ (64,570,219 ) $ (11,031,827 ) $ (131,066,443 ) $ (16,764,338 )
Add (Deduct) Impact of:
Net Interest and Other Financing Costs 2,601,785 669,130 5,011,817 1,017,717
Provision for Income Taxes 2,226,849 275,878 3,635,507 275,878
Amortization and Depreciation 5,046,897 708,783 7,767,605 1,577,283
Total Adjustments 9,875,531 1,653,791 16,414,929 2,870,878
EBITDA (Non-IFRS) $ (54,694,688 ) $ (9,378,036 ) $ (114,651,514 ) $ (13,893,460 )
EBITDA (Non-IFRS) $ (54,694,688 ) $ (9,378,036 ) $ (114,651,514 ) $ (13,893,460 )
Add (Deduct) Impact of:
Transaction Costs 5,381,648 2,211,536 6,804,999 2,144,611
Share-Based Compensation 11,470,365 288,494 22,653,899 539,916
Other Non-Cash Operating Costs (6,064,684 ) (4,785,050 )
Total Adjustments 10,787,329 2,500,030 24,673,848 2,684,527
Adjusted EBITDA (Non-IFRS) $ (43,907,359 ) $ (6,878,006 ) $ (89,977,666 ) $ (11,208,933 )

SOURCE: MedMen Enterprises

logo

Contacts

OFFICER:
Adam Bierman
Chief Executive Officer
Email: info@medmen.com
(855) 292-8399

or

MEDIA CONTACT:
Briana Chester
Senior Publicist
Email: briana.chester@medmen.com
(424) 888-4260

or

INVESTOR RELATIONS CONTACT:
Stéphanie Van Hassel
Head of Investor Relations
Email: investors@medmen.com
(323) 705-3025

Tags: , , ,

Important Links

Sponsored Message

View Rate Card